Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


University of Florida begins iPod® trial with SPI-1005 to prevent hearing loss

GAINESVILLE, Fla., Dec. 5, 2012 /PRNewswire/ -- The University of Florida (UF) has started enrolling subjects in a new study testing the oral drug developed by Sound Pharmaceuticals, Inc. (SPI-1005) to prevent hearing loss caused by loud music. Loud music or noise can induce temporary and permanent auditory threshold shifts (TTS or PTS). As people age, the level of PTS grows and results in a moderate loss of speech perception and discrimination, especially in noisy environments. In this Phase-II interventional clinical trial, volunteers will listen to pre-selected music delivered using an iPod® and insert earphones providing an exposure that results in small but reliable temporary threshold shifts. Volunteers will take a placebo or SPI-1005 before and after this exposure, to assess the extent to which TTS is reduced, and/or the rate of recovery is accelerated. SPI-1005 is an oral capsule that contains ebselen, a synthetic molecule that mimics the activity of Glutathione Peroxidase (GPx), a critical enzyme in the inner ear that protects it from damage caused by loud sounds or noise. In animal studies, GPx decreases in several important auditory structures including hair cells, supporting cells, nerve and lateral wall structures such as the stria vascularis. In several preclinical studies, ebselen treatment was shown to improve the GPx levels within these structures and to reduce the TTS and PTS induced by loud noise.

"The goal of this clinical trial is to determine if SPI-1005 can prevent or reduce the TTS induced by listening to loud music," said Dr. Colleen Le Prell, PhD, Associate Professor and Lead Investigator at the UF College of Public Health and Health Professions' Department of Speech, Language, and Hearing Sciences.

Currently there are no FDA approved drugs for the prevention and treatment of sensorineural hearing loss. "The enrollment of this Ph-II study represents a significant milestone for SPI and we are excited to advance of our clinical programs to achieve proof of concept in man" said Eric Lynch, PhD, President, SPI. Details of the study can be viewed online at www.clinicaltrials.gov by searching SPI-1005.

SPI is a privately held biopharmaceutical company in Seattle with a focus on developing the first drugs for the prevention and treatment of hearing loss.

Please visit http://www.SoundPharma.com
Eric Lynch, PhD, President, Sound Pharmaceuticals, Inc.
4010 Stone Way N Suite 120, Seattle WA 98103 Office: 206-634-2559

 

 

SOURCE Sound Pharmaceuticals, Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Web 2.0 Latest News
Earlier, I wrote a bit about traffic and the IoT. It's a big topic. The traffic problems of the developed and developing worlds seem so large, complex, and intractable to significant change in any reasonable timeframe. Consider Mexico City. There are more than 20 million people in ...
Is it just me, or has there been an explosion of buzz words lately? Don’t get me wrong, the IT industry innovates at a crazy pace normally, but it seems that things have been evolving faster than ever and that a fundamental change in the way things are done is underway. We can attribut...
My favorite writer, Gil Press, sums it up with, “It’s Official: The Internet Of Things Takes Over Big Data As The Most Hyped Technology” where he talks about how Gartner released its latest Hype Cycle for Emerging Technologies, and how big data has moved down the “trough of disillusion...
More and more Web sites and applications are being moved from Apache to nginx. While Apache is still the number one HTTP server with more than 60% on active Web sites, nginx has now taken over the 2nd place in the ranking and relegated Microsoft’s IIS to 3rd place. Among the top 10.000...
Getting one's arms around the Internet of Things is a daunting task. In addition to big IoT commitments from all of the big players in computing and telco, there are a number of smaller companies and startups working on devices and services to enable the future of enterprise IT and per...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE